msnho.com

The global RNA analysis market is poised for robust growth in the coming years, according to a new report by MarketsandMarkets.

The over-the-counter (OTC) test market is projected to reach USD 22.2 billion by 2024, growing at a compound annual growth rate of 11% during the forecast period of 2018-2024, according to a recent report by MarketsandMarkets.

The global patient safety software market is projected to reach USD 2.2 billion by 2024, growing at a CAGR of 11.2%, according to a new report by MarketsandMarkets. Key factors driving this growth include the rising need to reduce healthcare costs, increasing occurrences of medical errors and hospital-acquired infections, and growing government initiatives to improve patient safety and outcomes.

The global market for specialty picture archiving and communication systems (PACS) is expected to reach $3.5 billion by 2024, representing a compound annual growth rate of 6%, according to a new report from marketsandmarkets.

The global cleanroom technologies market is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2028, reaching $11.4 billion by 2028, according to a new report by MarketsandMarkets.

The global osteoarthritis therapeutics market is expected to grow at a compound annual growth rate of 8.7% from 2020 to 2025 to reach $11.0 billion by 2025, according to a recent report from MarketsandMarkets.

The global bioanalytical testing services market is poised for robust growth in the coming years, according to a new report from MarketsandMarkets.

The global fetal monitoring market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, at a CAGR of 7.3% during the forecast period.

The global AI in medical diagnostics market is expected to grow from $1.3 billion in 2023 to $3.7 billion by 2028, at a CAGR of 23.2% from 2023 to 2028.

The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth.